Drug Type Degradable Molecular Glue |
Synonyms inhibitor of cyclin-dependent kinase 12 (CDK12) and degrader of cyclin K (iLeadBMS), IL 2106, IL2106 |
Target |
Action degraders, inhibitors |
Mechanism CCNK degraders(cyclin K degraders), CDK12 inhibitors(cyclin dependent kinase 12 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HER2 negative Gastric Cancer | Preclinical | South Korea | 27 Feb 2024 | |
Triple Negative Breast Cancer | Preclinical | South Korea | 27 Feb 2024 | |
Metastatic breast cancer | Preclinical | South Korea | 19 Feb 2024 |